Scinovex
articleTop 10% cited

Preventing Renal Failure in Patients with Rhabdomyolysis: Do Bicarbonate and Mannitol Make a Difference?

The Journal of Trauma: Injury, Infection, and Critical Care · 2004 · Vol. 56(6) · pp. 1191–1196
Carlos BrownPeter RheeLinda S. ChanKelly EvansΔημήτριος ΔημητριάδηςGeorge C. Velmahos

Abstract

Abnormal CK levels are common among critically injured patients, and a CK level greater than 5,000 U/L is associated with RF. BIC/MAN does not prevent RF, dialysis, or mortality in patients with creatine kinase levels greater than 5,000 U/L. The standard of administering BIC/MAN to patients with post-traumatic rhabdomyolysis should be reevaluated.

Muscle and Compartmental DisordersTrauma, Hemostasis, Coagulopathy, ResuscitationElectrolyte and hormonal disordersMedicineRhabdomyolysisCreatine kinaseDialysisIntensive care unitCreatinineInternal medicineCreatine

MeSH terms

Creatine KinaseDiuretics, OsmoticDrug Therapy, CombinationFemaleHumansMaleMannitolMiddle AgedRhabdomyolysisRisk FactorsLogistic ModelsOdds RatioSodium BicarbonateAcute Kidney Injury
Citations
397
FWCI
12.03
field-weighted impact
References
20
Percentile
99%
vs. same field & year
Citations per year
References
Rhabdomyolysis
Journal of the American Society of Nephrology · 2000 · 657 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Preventing Renal Failure in Patients with Rhabdomyolysis: Do Bicarbonate and Mannitol Make a Difference? · Scinovex